ClinicalTrials.gov record
Completed No phase listed Observational

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

ClinicalTrials.gov ID: NCT03788746

Public ClinicalTrials.gov record NCT03788746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 8:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Non-Interventional Study to Assess the Prevalence of PD-L1 Expression in the First-Line Setting of Locally Advanced/Unresectable or Metastatic Urothelial Carcinoma

Study identification

NCT ID
NCT03788746
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Lead sponsor
AstraZeneca
Industry
Enrollment
181 participants

Conditions and interventions

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years to 130 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 16, 2019
Primary completion
Jan 11, 2022
Completion
May 24, 2023
Last update posted
Feb 21, 2024

2019 – 2023

United States locations

U.S. sites
58
U.S. states
25
U.S. cities
57
Facility City State ZIP Site status
Research Site Little Rock Arkansas 72211
Research Site Glendale California 91204
Research Site Los Angeles California 90048
Research Site Los Angeles California 90067
Research Site Monterey California 93940
Research Site Santa Rosa California 95403
Research Site Denver Colorado 80211
Research Site Englewood Colorado 80113
Research Site Hartford Connecticut 06106
Research Site Stamford Connecticut 06904
Research Site Boca Raton Florida 33486
Research Site Hialeah Florida 33016-1815
Research Site Jacksonville Florida 32256
Research Site Augusta Georgia 30912
Research Site Roswell Georgia 30076
Research Site Geneva Illinois 60134
Research Site Harvey Illinois 60426
Research Site Lake Barrington Illinois 60010
Research Site Naperville Illinois 60540
Research Site Greenwood Indiana 46143
Research Site Lafayette Indiana 47904
Research Site Muncie Indiana 47303
Research Site Cedar Rapids Iowa 52403
Research Site Waterloo Iowa 50703
Research Site Kansas City Kansas 66160
Research Site Wichita Kansas 67226
Research Site Baton Rouge Louisiana 70809
Research Site Shreveport Louisiana 71106
Research Site Brewer Maine 04412
Research Site Lewiston Maine 04240
Research Site Grand Rapids Michigan 49503-2563
Research Site Duluth Minnesota 55805
Research Site Saint Cloud Minnesota 56303
Research Site Bridgeton Missouri 63044
Research Site Las Vegas Nevada 89106
Research Site Berkeley Heights New Jersey 07922
Research Site East Brunswick New Jersey 08816
Research Site Englewood New Jersey 07631
Research Site Freehold New Jersey 07728
Research Site Little Silver New Jersey 07739
Research Site Mount Laurel New Jersey 08054
Research Site Albany New York 12206
Research Site Johnson City New York 13790
Research Site Port Jefferson Station New York 11776
Research Site Greenville North Carolina 27834
Research Site Cincinnati Ohio 45267
Research Site Kettering Ohio 45429
Research Site Myrtle Beach South Carolina 29572
Research Site Knoxville Tennessee 37920
Research Site Nashville Tennessee 37209
Research Site Temple Texas 76508
Research Site The Woodlands Texas 77380
Research Site Virginia Beach Virginia 23462
Research Site Olympia Washington 98502
Research Site Renton Washington 98055
Research Site Seattle Washington 98101
Research Site Tacoma Washington 98405
Research Site Wenatchee Washington 98801

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03788746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 21, 2024 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03788746 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →